Loxapine versus chlorpromazine in paranoid schizophrenia: A double-blind study

V. B. Tuason; J. I. Escobar; M. Garvey; B. Schiele

Loxapine versus chlorpromazine in paranoid schizophrenia: A double-blind study

V. B. Tuason, J. I. Escobar, M. Garvey, B. Schiele

Research output: Contribution to journal › Article › peer-review

Abstract

Newly admitted paranoid schizophrenic patients (N = 68) were treated with either loxapine or chlorpromazine for up to 4 weeks. Mean maximum dosages were 84 mg/day of loxapine and 820 mg/day of chlorpromazine. Loxapine showed efficacy superior to that of chlorpromazine, confirming earlier retrospective findings. Adverse reactions were also less troublesome with loxapine.

Original language	English (US)
Pages (from-to)	158-163
Number of pages	6
Journal	Journal of Clinical Psychiatry
Volume	45
Issue number	4 I
State	Published - 1984
Externally published	Yes

All Science Journal Classification (ASJC) codes

Psychiatry and Mental health

Cite this

@article{ddd0f57c0369413baeeb307498cd8d3e,

title = "Loxapine versus chlorpromazine in paranoid schizophrenia: A double-blind study",

abstract = "Newly admitted paranoid schizophrenic patients (N = 68) were treated with either loxapine or chlorpromazine for up to 4 weeks. Mean maximum dosages were 84 mg/day of loxapine and 820 mg/day of chlorpromazine. Loxapine showed efficacy superior to that of chlorpromazine, confirming earlier retrospective findings. Adverse reactions were also less troublesome with loxapine.",

author = "Tuason, {V. B.} and Escobar, {J. I.} and M. Garvey and B. Schiele",

year = "1984",

language = "English (US)",

volume = "45",

pages = "158--163",

journal = "Journal of Clinical Psychiatry",

issn = "0160-6689",

publisher = "Physicians Postgraduate Press Inc.",

number = "4 I",

}

TY - JOUR

T1 - Loxapine versus chlorpromazine in paranoid schizophrenia

T2 - A double-blind study

AU - Tuason, V. B.

AU - Escobar, J. I.

AU - Garvey, M.

AU - Schiele, B.

PY - 1984

Y1 - 1984

N2 - Newly admitted paranoid schizophrenic patients (N = 68) were treated with either loxapine or chlorpromazine for up to 4 weeks. Mean maximum dosages were 84 mg/day of loxapine and 820 mg/day of chlorpromazine. Loxapine showed efficacy superior to that of chlorpromazine, confirming earlier retrospective findings. Adverse reactions were also less troublesome with loxapine.

AB - Newly admitted paranoid schizophrenic patients (N = 68) were treated with either loxapine or chlorpromazine for up to 4 weeks. Mean maximum dosages were 84 mg/day of loxapine and 820 mg/day of chlorpromazine. Loxapine showed efficacy superior to that of chlorpromazine, confirming earlier retrospective findings. Adverse reactions were also less troublesome with loxapine.

UR - http://www.scopus.com/inward/record.url?scp=0021319522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021319522&partnerID=8YFLogxK

M3 - Article

C2 - 6370967

AN - SCOPUS:0021319522

SN - 0160-6689

VL - 45

SP - 158

EP - 163

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

IS - 4 I

ER -

Loxapine versus chlorpromazine in paranoid schizophrenia: A double-blind study

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this